Application no. and date | 15845664.0 (espacenet) (Federated) (European Patent Register), 20150930 | Patent/reg. no. and date | DK/EP 3201320, 20231011 | Publication date | 20170809 | Priority no. and date | US 201462057842 P, 20140930, US 201462057847 P, 20140930, US 201562112463 P, 20150205, US 201562135345 P, 20150319 | EP pub. no. and date |
EP 3201320 20170809 | Effective date | | Applicant/owner | Amicus Therapeutics, Inc., 3675 Market Street
Philadelphia, PA 19104, US | Applicant ref. no. | 1695342 | Inventor | DO, Hung, 819 Yearling Drive
New Hope, PA 18938, US, GOTSCHALL, Russell, 2065 Country Club Drive
Doylestown, PA 18901, US | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | Opponent | | IPC Class | A61K 48/00 (2006.01) , C12N 15/09 (2006.01) , C12N 5/07 (2010.01) , C12N 5/10 (2006.01) , C12N 9/40 (2006.01) | Title | HØJPOTENT SUR ALFA-GLUCOSIDASE MED FORBEDREDE CARBOHYDRATER | Int. application no. | US2015053252 | Int. publication no. | WO2016054231 | Related patent (certificate) | CA 2024 00012 | Status | Rettet DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|